|
91
|
300
|
8bzvA |
Sars-cov-2 nsp10-16 methyltransferase in complex with adenosine |
|
80
|
299
|
7pzqA |
Oxidized form of sars-cov-2 main protease determined by xfel radiation |
|
230
|
931
|
8gwfA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
26
|
116
|
8bzvB |
Sars-cov-2 nsp10-16 methyltransferase in complex with adenosine |
|
101
|
593
|
8gwfE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
80
|
306
|
7pxzA |
Reduced form of sars-cov-2 main protease determined by xfel radiation |
|
53
|
187
|
8gwfB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwfG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
85
|
302
|
7tekA |
Sars-cov-2 3clpro in complex with n-(4-(1h-pyrazol-4-yl)phenyl)-n-(3-chlorobenzyl)-2-(pyridin-3-yl)acetamide |
|
88
|
302
|
7telA |
Sars-cov-2 3clpro in complex with n-(4-(1h-imidazol-4-yl)phenyl)-n-(3-chloro-5-fluorobenzyl)-2-(isoquinolin-4-yl)acetamide |
|
89
|
309
|
7wfcA |
X-ray structure of hku1-plp2(cys109ser) catalytic mutant in complex with free ubiquitin |
|
36
|
181
|
8aouA |
Solution nmr structure of full-length nsp1 from sars-cov-2. |
|
24
|
154
|
7zmiB |
Crystal structure of unlinked ns2b_ns3 protease from zika virus in complex with inhibitor mi-2113 |
|
28
|
154
|
7zlcB |
Crystal structure of unlinked ns2b_ns3 protease from zika virus in complex with inhibitor mi-2224 |
|
1
|
39
|
7zldA |
Crystal structure of unlinked ns2b_ns3 protease from zika virus in complex with inhibitor mi-2223 |
|
1
|
39
|
7zmiA |
Crystal structure of unlinked ns2b_ns3 protease from zika virus in complex with inhibitor mi-2113 |
|
86
|
305
|
7zqvA |
Structure of the sars-cov-2 main protease in complex with ag7404 |
|
0
|
39
|
7zlcA |
Crystal structure of unlinked ns2b_ns3 protease from zika virus in complex with inhibitor mi-2224 |
|
25
|
155
|
7zldB |
Crystal structure of unlinked ns2b_ns3 protease from zika virus in complex with inhibitor mi-2223 |
|
25
|
94
|
8hdaA |
Crystal structure of ubl1 (residues 18-111) of sars-cov-2 |
|
77
|
305
|
7qkaA |
Crystal structure of sars-cov-2 main protease in complex with covalently bound gc376 |
|
29
|
155
|
8aqbB |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2257 |
|
44
|
187
|
8gwnB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
230
|
931
|
8gwgA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwgG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
53
|
187
|
8gwiB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
101
|
593
|
8gwgE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
16
|
113
|
8gwiG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
101
|
593
|
8gwiE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
0
|
40
|
8aqaA |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2260 |
|
112
|
593
|
8gwnE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
0
|
40
|
8aqbA |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2257 |
|
184
|
926
|
8gwnA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
29
|
155
|
8aqaB |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2260 |
|
29
|
154
|
8aqkB |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2258 |
|
21
|
113
|
8gwnG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
230
|
931
|
8gwiA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
0
|
40
|
8aqkA |
Crystal structure of unlinked ns2b-ns3 protease from zika virus in complex with inhibitor mi-2258 |
|
53
|
187
|
8gwgB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
69
|
306
|
8ey2A |
Cryo-em structure of sars-cov-2 main protease c145s in complex with n-terminal peptide |
|
24
|
116
|
8bsdB |
Sars-cov-2 nsp10-16 methyltransferase in complex with tubercidin |
|
91
|
301
|
7zv7A |
Crystal structure of sars cov-2 main protease in complex with an inhibitor 57 |
|
201
|
926
|
8gwoA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
61
|
306
|
7zb8A |
Crystal structure of sars-cov-2 main protease (mpro) variant k61a at 2.48 a resolution |
|
82
|
305
|
7zv8A |
Crystal structure of sars cov-2 main protease in complex with an inhibitor 58 |
|
91
|
301
|
8bsdA |
Sars-cov-2 nsp10-16 methyltransferase in complex with tubercidin |
|
85
|
306
|
7zb7A |
Crystal structure of sars-cov-2 main protease (mpro) variant y54f at 1.63 a resolution |
|
63
|
306
|
7zb6A |
Crystal structure of sars-cov-2 main protease (mpro) variant c44s at 2.12 a resolution |
|
21
|
72
|
8gwoC |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
51
|
187
|
8gwoB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
